A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate in Patients With Schizophrenia

Mise à jour : Il y a 4 ans
Référence : NCT01559272

Femme et Homme

Extrait

The purpose of this study is to assess the pharmacokinetics, safety, and tolerability of a paliperidone palmitate 3-month formulation in patients with schizophrenia.


Critère d'inclusion

  • Schizophrenia


Liens